SANTIAGO
MORENO GUILLÉN
Investigador hasta 2007
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (22)
2024
-
Respiratory syncytial virus: A new era
Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148
2023
-
Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?
Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469
-
Tuberculosis in Spain: An opinion paper
Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583
2022
-
Actions and attitudes on the immunized patients against SARS-CoV-2
Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15
-
COVID in Pediatric Age: an opinion paper
Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343
-
COVID-19: Some unresolved issues
Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434
-
Lessons from COVID-19 for future disasters: an opinion paper
Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 444-454
-
Monkeypox in humans: a new outbreak
Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518
-
Persistence and viability of SARS-CoV-2 in primary infection and reinfections
Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 1-6
2021
-
New variants of SARS-CoV-2
Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428
-
Post-covid syndrome: A reflection and opinion paper
Revista Espanola de Quimioterapia, Vol. 34, Núm. 4, pp. 269-279
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
2016
2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
2010
-
Opportunistic infections and organ-specific diseases in HIV-1-infected children: A cohort study (1990-2006)
HIV Medicine, Vol. 11, Núm. 4, pp. 245-252
2007
-
Costes de la toxicidad asociada a los análogos de nucleósidos inhibidores de la transcriptasa inversa en pacientes con infección por el VIH-1
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 2, pp. 98-107
2005
-
Treatment-limiting toxicities associated with nucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study
Current Therapeutic Research - Clinical and Experimental, Vol. 66, Núm. 2, pp. 117-129
2004
-
Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus-Infected Patients with Chronic Hepatitis C: A European Collaborative Study
Clinical Infectious Diseases, Vol. 38, Núm. 1, pp. 128-133
2001
-
Predicting tuberculosis among HIV-infected patients admitted to hospital: Comparison of a model with clinical judgment of infectious disease specialists
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Núm. 11, pp. 779-784
2000
-
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain
AIDS, Vol. 14, Núm. 6, pp. 727-732